Treace Medical Concepts, Inc. ( TMCI) - Key Metrics
TMCI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.70 | -$0.24 | -$0.07 | -$0.11 |
| 2026Q1 | $0.73 | -$0.28 | $0.11 | $0.06 |
| 2025Q4 | $0.98 | -$0.15 | -$0.13 | -$0.16 |
| 2025Q3 | $0.79 | -$0.26 | -$0.14 | -$0.19 |
| 2025Q2 | $0.75 | -$0.28 | -$0.05 | -$0.12 |
TMCI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.15 |
| 2026Q1 | 0% | -1.20 |
| 2025Q4 | 0% | -4.08 |
| 2025Q3 | 0% | -6.45 |
| 2025Q2 | 0% | -5.25 |
TMCI
Price: $3.96
52 week price:
Earnings Per Share: -0.92 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 631400
Market Capitalization: 271.2 million